Concepedia

Allison Keshishian

AK

37

Publications

1.7K

Citations

23

H-Index

2016

Active since

Affiliations

STATinMED (United States)(Current)

Pfizer (United States)

Bristol-Myers Squibb (United States)

New York City College of Technology

City University of New York

Allison Keshishian is an author at STATinMED (United States) specializing in public health, medicine, and cardiovascular disease.

ORCID

Top concepts

Publications per year

2016–2023

37

Publications

37

Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients

Gregory Y.H. Lip, Allison Keshishian, Xiaoyan Li et al. · Stroke · 2018 · 308 citations · Full text

, , +20

Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin

Allison Keshishian, Shital Kamble, Xianying Pan et al. · Thrombosis and Haemostasis · 2016 · 258 citations · Full text

Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in “real-world” clinical practice

Xiaoyan Li, Steve Deitelzweig, Allison Keshishian et al. · Thrombosis and Haemostasis · 2017 · 158 citations · Full text

Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin in the United States Medicare population

Alpesh Amin, Allison Keshishian, Jeffrey Trocio et al. · Current Medical Research and Opinion · 2017 · 70 citations · Full text

Examining the Effect of Medication Adherence on Risk of Subsequent Fracture Among Women with a Fragility Fracture in the U.S. Medicare Population

Allison Keshishian, Natalie Boytsov, Russel Burge et al. · Journal of Managed Care & Specialty Pharmacy · 2017 · 58 citations · Full text

Rows per page

1–5 of 37